ATE527358T1 - Ribosomen inaktivierendes protein vom typ-1 - Google Patents

Ribosomen inaktivierendes protein vom typ-1

Info

Publication number
ATE527358T1
ATE527358T1 AT98928659T AT98928659T ATE527358T1 AT E527358 T1 ATE527358 T1 AT E527358T1 AT 98928659 T AT98928659 T AT 98928659T AT 98928659 T AT98928659 T AT 98928659T AT E527358 T1 ATE527358 T1 AT E527358T1
Authority
AT
Austria
Prior art keywords
protein
ribosome
inactivative
type
conjugate
Prior art date
Application number
AT98928659T
Other languages
English (en)
Inventor
Fiorenzo Stirpe
Andrea Bolognesi
Original Assignee
Pangenetics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenetics Bv filed Critical Pangenetics Bv
Application granted granted Critical
Publication of ATE527358T1 publication Critical patent/ATE527358T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98928659T 1997-06-06 1998-06-08 Ribosomen inaktivierendes protein vom typ-1 ATE527358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201725 1997-06-06
PCT/NL1998/000336 WO1998055623A1 (en) 1997-06-06 1998-06-08 Type-1 ribosome-inactivating protein

Publications (1)

Publication Number Publication Date
ATE527358T1 true ATE527358T1 (de) 2011-10-15

Family

ID=8228417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928659T ATE527358T1 (de) 1997-06-06 1998-06-08 Ribosomen inaktivierendes protein vom typ-1

Country Status (6)

Country Link
US (2) US6680296B1 (de)
EP (1) EP0975762B1 (de)
AT (1) ATE527358T1 (de)
AU (1) AU8040898A (de)
CA (1) CA2295189C (de)
WO (1) WO1998055623A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
AU2001268427B2 (en) 2000-06-16 2007-03-29 Glaxosmithkline Intellectual Property Limited Antibodies that immunospecifically bind to blys
AU2001288301A1 (en) 2000-08-18 2002-03-04 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
CA2438682A1 (en) 2001-02-20 2002-08-29 Zymogenetics, Inc. Antibodies that bind both bcma and taci
EP1241267A3 (de) * 2001-03-14 2004-01-02 Viscum AG Enzym-Aktivitätstest mittels fluoreszenzmarkierter Oligonukleotid-Substrate
EP1497415B1 (de) 2002-04-19 2010-12-29 ZymoGenetics, L.L.C. Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand
DK2829283T3 (en) 2003-04-30 2017-09-18 Univ Zuerich METHOD OF TREATING CANCER USING IMMUNOTOXIN
PL1737961T3 (pl) * 2004-03-19 2013-12-31 Merck Patent Gmbh Zmodyfikowane białka bouganiny, cytotoksyny i sposoby oraz ich zastosowania
AU2005318836B2 (en) 2004-12-21 2012-03-22 Viventia Bio Inc. Cancer specific antibody and cell surface proteins
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
WO2008128330A1 (en) * 2007-04-19 2008-10-30 Viventia Biotech Inc. Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
CA2700815A1 (en) 2007-09-27 2009-04-02 Viventia Biotech Inc. Optimized nucleic acid sequences for the expression of vb4-845
WO2009108898A2 (en) * 2008-02-27 2009-09-03 Bioo Scientific Corporation Production and uses of type 1 ribosome inactivating proteins
KR20140039157A (ko) * 2011-01-07 2014-04-01 발리언트 바이오파마 에스디엔 비에이치디 항미생물성 융합 화합물 및 그의 용도
BR112016007232A2 (en) 2013-10-02 2018-01-23 Viventia Bio Inc. anti-epcam antibodies and methods of use
JP6847846B2 (ja) 2015-03-12 2021-03-24 セセン バイオ，インコーポレイテッド Ｅｐｃａｍ陽性膀胱癌を標的とする投薬戦略
AU2016228755B2 (en) 2015-03-12 2020-09-10 Viventia Bio Inc. Methods of treatment for EPCAM positive bladder cancer
CA3078434A1 (en) 2017-10-10 2019-04-18 Medicenna Therapeutics, Inc. Il-4-fusion formulations for treatment of central nervous system (cns) tumors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255843A1 (en) * 1973-12-26 1975-07-25 Chatenoud Gilles Device for watering plants in window boxeseetc - has water container, wick, distributor and filler pipe
GB2095083A (en) 1981-03-20 1982-09-29 Fah Ah Ngau Automatic watering system for plants
DE8520444U1 (de) * 1985-07-16 1986-01-16 Fers, Zlatko Rajmund, 2117 Tostedt Vorrichtung zum Bewässern von Pflanzen und Gestecken
FR2646750A1 (fr) 1989-05-09 1990-11-16 Stroppa Mauro Dispositif modulaire en kit a capacite variable a humidification capillaire permettant de transformer tout recipient quelconque en un bac a plantes a reserve d'eau
US5376546A (en) 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
AU6912294A (en) 1993-05-12 1994-12-12 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5597569A (en) 1993-10-25 1997-01-28 Bristol-Myers Squibb Company Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica
US5535547A (en) * 1995-09-15 1996-07-16 Brunengo; P. John Conduit and float gauge apparatus

Also Published As

Publication number Publication date
WO1998055623A1 (en) 1998-12-10
EP0975762A1 (de) 2000-02-02
CA2295189A1 (en) 1998-12-10
CA2295189C (en) 2010-11-23
AU8040898A (en) 1998-12-21
EP0975762B1 (de) 2011-10-05
US6680296B1 (en) 2004-01-20
US7479552B2 (en) 2009-01-20
US20040266994A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
AU8040898A (en) Type-1 ribosome-inactivating protein
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
PT730608E (pt) Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes
EA200001041A1 (ru) Антитела к cd23, их производные и их терапевтическое применение
NO901986L (no) Nytt antistoff-leveringssystem for biologisk respons-modifiserende midler.
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
DE69637147D1 (de) Transportproteine und deren verwendungen
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
TR199700610A3 (tr) Düsük molekül agirlikli çözünür, tümör nekroz faktörü tip-I ve tip-II proteinleri.
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
DE69434384D1 (de) Metalkomplexbildner
ATE322503T1 (de) Gefrierschutzprotein
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
ATE281528T1 (de) Rekombinante ribonuklease proteine
ATE331728T1 (de) Proteinmarkierung mit radioaktivem phospor und gezielte radiotherapie
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
CA2265444A1 (en) Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
EA200001127A1 (ru) Бактериальные феромоны и их использование
DE69534753D1 (de) Nierenpolycystose-gen
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties